King's College London

Research portal

Poor outcome and prolonged persistence of SARS-CoV-2 RNA in COVID-19 patients with haematological malignancies; King's College Hospital experience

Research output: Contribution to journalLetter

Vallari Shah, Thinzar Ko Ko, Mark Zuckerman, Jennifer Vidler, Sobia Sharif, Varun Mehra, Shreyans Gandhi, Andrea Kuhnl, Deborah Yallop, Daniele Avenoso, Carmel Rice, Robin Sanderson, Anita Sarma, Judith Marsh, Hugues de Lavallade, Pramila Krishnamurthy, Piers Patten, Reuben Benjamin, Victoria Potter, M Mansour Ceesay & 5 more Ghulam J Mufti, Sam Norton, Antonio Pagliuca, James Galloway, Austin G Kulasekararaj

Original languageEnglish
Pages (from-to)e279-e282
JournalBritish Journal of Haematology
Issue number5
Early online date11 Jun 2020
E-pub ahead of print11 Jun 2020
Published1 Sep 2020

Bibliographical note

This article is protected by copyright. All rights reserved.

King's Authors


Severe acute respiratory syndrome coronavirus-2 (SARS-CoV-2), emerged at the end of 2019 and caused an infection named COVID-19 (Guan, Ni et al. 2020). Patients with compromised immune systems are at increased risk of complications but this risk is not precisely defined (Liang, Guan et al. 2020). Although age, gender, comorbidities and ethnicity are risk factors for adverse outcomes (Huang, Wang et al. 2020), various pre-existing conditions, including haematological cancers, have also been reported to correlate with poor outcomes (Aries, Davies et al. 2020, He, Chen et al. 2020, Malard, Genthon et al. 2020, Martin-Moro, Marquet et al. 2020, medRxiv 2020).

View graph of relations

© 2020 King's College London | Strand | London WC2R 2LS | England | United Kingdom | Tel +44 (0)20 7836 5454